GENERIC - The Salt Lake Tribune News from The Salt Lake Tribune en-us (Webmaster) Mylan to buy Abbott business line in $5.3B deal <div class="hnews hentry item"> <h4><a class="url entry-title" href="">Mylan to buy Abbott business line in $5.3B deal</a></h4> <span class="author source-org vcard"><span class="org fn">The Associated Press</span></span> <h5><span class="updated" title="2014-07-14T12:45:55.596-06:00">Updated Jul 14, 2014 12:45PM MDT</span></h5> <div class ="entry-content">Pittsburgh • Generic drugmaker Mylan is buying Abbott Laboratories’ generic-drugs business in developed markets for stock valued at about $5.3 billion. Mylan said Monday the deal will diversify and expand its business outside the U.S. The combined company will be organized in the Netherlands, which will help reduce its tax expenses. The company will keep its headquarters near Pittsburgh. The deal is expected to lower Mylan’s tax rate to approximately 20 percent to 21 percent in the first full ye...</div> <h5><a rel="item-license" href="#license-581825742014-07-14T12:45:55.596-06:00" id="#license-2014-07-14T12:45:55.596-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> Mon, 14 Jul 2014 12:45:55 MDT